AQP9 and metabolic dysfunction-associated steatotic liver disease: Cheng et al.'s study showed that AQP9 could affect lipid metabolism in NAFLD, and knocking out AQP9 can decrease lipid toxicity, which subsequently lowers inflammation and oxidative stress, ultimately hindering the progression of NAFLD 26.